Related Experiment Video
Updated: Apr 27, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Sulcus-fixated intraocular lens implantation for the management of negative dysphotopsia
Tomas R Burke1, Larry Benjamin1
1From the Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, United Kingdom.
Purpose:
To determine whether intraocular lens (IOL) exchange with insertion of a sulcus-fixated IOL is an effective treatment for the management of pseudophakic negative dysphotopsia.
Setting:
Department of Ophthalmology, Stoke Mandeville Hospital, Buckinghamshire, United Kingdom.
Design:
Case series.
Methods:
Participants in the study were recruited prospectively from the clinic at the time of diagnosis or retrospectively from the operating room logs by identifying all patients who had IOL exchanges over a 4-year period (2009 to 2012).
Results:
Five eyes of 5 women with negative dysphotopsia were treated with IOL exchange and replacement with a 3-piece IOL (Acrysof MA60AC) inserted in the ciliary sulcus. All patients had a resolution of the negative dysphotopsia symptoms. One patient had primary insertion of a sulcus IOL in the fellow eye and did not develop negative dysphotopsia symptoms.
Conclusion:
Intraocular lens exchange with insertion of a 3-piece IOL in the ciliary sulcus appears to be a safe and effective treatment for the management of pseudophakic negative dysphotopsia.
Financial Disclosure:
Neither author has a financial or proprietary interest in any material or method mentioned.
More Related Videos
05:46Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Ophthalmic Drug Delivery Systems